# Florida Healthcare Marketing Compliance Rules - FL Medical Board and AG

Florida Board of Medicine advertising rules under F.A.C. 64B8, the Florida Deceptive and Unfair Trade Practices Act (FDUTPA), and specific enforcement patterns in med spa, weight loss, and regenerative medicine marketing.

Canonical page: https://regencompliance.ai/state/florida


## Overview

Florida is a healthcare practice destination - particularly for regen medicine, aesthetic surgery, and concierge medicine - and the regulatory environment reflects that. The Florida Board of Medicine (FBM) enforces specific advertising rules under F.A.C. 64B8, which include physician qualification disclosure, specialty claim rules, and deceptive-advertising prohibitions. FDUTPA provides state-AG and private enforcement over deceptive practices. Florida has been a particularly active jurisdiction for enforcement against stem cell and regenerative medicine marketing, given the volume of such practices in the state.


## Florida Board of Medicine (FBM)

The FBM enforces F.A.C. 64B8-11 and related advertising rules. Specific focus areas include the 'board-certified' rule (requires ABMS or equivalent), specialty-claim accuracy, and supervision requirements in aesthetic practices. The FBM has also been active on cosmetic surgery marketing specifically - including handling of complications and the marketing of medical tourism.


## State attorney general focus

FDUTPA gives the Florida AG consumer-protection authority over deceptive healthcare marketing. Recent enforcement has included stem cell clinic marketing, telehealth weight-loss advertising, and aesthetic practice package pricing. FDUTPA also permits private action, creating parallel class-action exposure.


## Focus areas

- **Stem cell / regenerative medicine marketing**: Florida has a high concentration of regen medicine practices, and the state AG has taken parallel state action on marketing that has also drawn FDA federal enforcement. Marketing claims about disease treatment, FDA approval, and outcome guarantees are the primary triggers.
- **Medical tourism marketing**: Florida is a medical-tourism market, particularly for aesthetic surgery. Marketing to out-of-state and international patients requires disclosure of Florida-specific licensure, supervision arrangements for post-op care, and complications handling.
- **Weight loss and GLP-1 advertising**: Florida's telehealth-friendly environment has produced substantial weight-loss practice growth - and corresponding state AG attention to marketing that minimizes clinical evaluation or misrepresents medication options.
- **'Board-certified' enforcement**: Florida Board of Medicine enforces specific rules on 'board-certified' language - requiring ABMS or Florida-recognized equivalent certification. Non-ABMS board certification claims must be qualified.


## Patterns that draw enforcement attention

- **Stem cell marketing with disease-treatment claims**: Florida has parallel state-level enforcement on patterns that also trigger FDA action.
- **Aesthetic surgery marketing without clear Florida-licensure disclosure**: Medical tourism context makes licensure disclosure a state-specific concern.
- **'Board-certified' without ABMS-or-equivalent qualifier**: FBM specifically enforces this pattern.
- **Compounded GLP-1 marketed as brand-name equivalent**: Florida AG has initiated enforcement on this pattern under FDUTPA.
- **Outcome guarantees in aesthetic marketing**: Common FDUTPA private-action and AG-action basis.


## Specialty notes

- Regen medicine - Florida has particularly active state-level enforcement due to practice volume.
- Aesthetic surgery - 'board-certified' and medical-tourism disclosure are active focus areas.
- Weight loss / telehealth - AG activity under FDUTPA has grown.
- Med spas - FBM supervision enforcement is in line with other heavily-enforced states.
- Dental - Florida Board of Dentistry has separate advertising rules.


## Disclaimer

This summary reflects general patterns in Florida healthcare marketing enforcement; it is not legal advice. For state-specific guidance on your practice, consult a Florida-licensed healthcare marketing attorney.

---

RegenCompliance is FDA/FTC compliance scanning software for healthcare marketing, operated by Regen Portal LLC. Educational compliance tool, not legal advice. Not affiliated with the FDA or FTC. Contact: support@regencompliance.ai. Full site index for AI agents: https://regencompliance.ai/llms.txt